Series
Mitral valve procedures
Status
Published
Date
Number of report
008
Transcatheter mitral valve leaflet repair using mitral clips for mitral regurgitation
Ask the expert
Report presents summary of the reimbursement situation for a transcatheter mitral valve leaflet repair using mitral clips for mitral regurgitation.
Manufacturers and developers of the technology include:
- Abbott Vascular (MitraClip)
Report includes essential information about reimbursement and national funding of the transcatheter mitral valve leaflet repair using mitral clips for mitral regurgitation, including:
- Brief overview of reimbursement system for medical devices
- Procedure coding for technology
- Diagnosis coding
- Payment mechanism for technology
- Reimbursement tariffs for technology
- Restrictions in indications or scenarios for use of technology
- Policy considerations by payers and policy-makers about technology
Reimbursement information is provided for the following geographies:
- Austria
- Belgium
- Denmark
- England (UK)
- France
- Germany
- Italy
- Netherlands
- Norway
- Sweden
- Switzerland
It is also possible to add analysis in Czech Republic, Finland, Hungary, Romania, Russia and Turkey.
1. Introduction and summary
2. Executive summary table
3. Methodology
4. Reimbursement analysis in Austria
4.1. Overview of the reimbursement system
4.2. Reimbursement for transcatheter mitral valve leaflet repair using mitral clips
4.2.1. Payment mechanism and reimbursement tariffs
4.2.2. Health technology assessment by LBI-HTA
5. Reimbursement analysis in Belgium
5.1. Overview of the reimbursement system
5.2. Reimbursement for transcatheter mitral valve leaflet repair using mitral clips
5.2.1. Payment mechanism and reimbursement tariffs
5.2.2. Policy considerations
5.2.2.1. Reimbursement framework for transcatheter mitral valve leaflet repair using mitral clips
by INAMI
6. Reimbursement analysis in Denmark
6.1. Overview of the reimbursement system
6.2. Reimbursement for transcatheter mitral valve leaflet repair using mitral clips
6.2.1. Payment mechanism and reimbursement tariffs
7. Reimbursement analysis in England
7.1. Overview of the reimbursement system
7.2. Reimbursement for transcatheter mitral valve leaflet repair using mitral clips
7.2.1. Payment mechanism and reimbursement tariffs
7.2.2. Policy considerations
7.2.2.1. National commissioning by NHS England
7.2.2.2. National commissioning of percutaneous mitral valve leaflet repair for mitral regurgitation by NHS England
7.2.2.3. Health technology assessment by NICE
8. Reimbursement analysis in France
8.1. Overview of the reimbursement system
8.2. Reimbursement for transcatheter mitral valve leaflet repair using mitral clips
8.2.1. Procedure coding
8.2.2. Diagnosis coding
8.2.3. Payment mechanism and reimbursement tariffs
8.2.4. Brand-specific reimbursement for mitral clip system
8.2.5. Policy considerations
8.2.6. Coverage with evidence development
8.2.6.1. Transcatheter mitral valve leaflet repair using mitral clips for mitral regurgitation
9. Reimbursement analysis in Germany
9.1. Overview of the reimbursement system
9.2. Reimbursement for transcatheter mitral valve leaflet repair using mitral clips
9.2.1. Procedure coding
9.2.2. Diagnosis coding
9.2.3. Payment mechanism and reimbursement tariffs
9.2.4. Policy considerations
10. Reimbursement analysis in Italy
10.1. Overview of the reimbursement system
10.2. Reimbursement for transcatheter mitral valve leaflet repair using mitral clips
10.2.1. Procedure coding at national level
10.2.2. Procedure coding at regional level (Emilia-Romagna region)
10.2.3. Diagnosis coding
10.2.4. Payment mechanism and reimbursement tariffs at national level
10.2.5. Payment mechanism and reimbursement tariffs at regional level
10.2.6. Policy considerations
11. Reimbursement analysis in the Netherlands
11.1. Overview of the reimbursement system
11.2. Reimbursement for transcatheter mitral valve leaflet repair using mitral clips
11.2.1. Procedure coding
11.2.2. Material coding
11.2.3. Diagnosis coding
11.2.4. Payment mechanism and reimbursement tariffs
11.2.5. Policy considerations
11.2.6. Health technology assessment by National Healthcare Institute
12. Reimbursement analysis in Norway
12.1. Overview of the reimbursement system
12.2. Reimbursement for transcatheter mitral valve leaflet repair using mitral clips
12.2.1. Procedure coding
12.2.2. Diagnosis coding
12.2.3. Payment mechanism and reimbursement tariffs
12.2.4. Policy considerations
13. Reimbursement analysis in Sweden
13.1. Overview of the reimbursement system
13.2. Reimbursement for transcatheter mitral valve leaflet repair using mitral clips
13.2.1. Procedure coding
13.2.2. Diagnosis coding
13.2.3. Payment mechanism and reimbursement tariffs
13.2.4. Policy considerations
13.2.4.1. Recommendations for transcatheter mitral valve leaflet repair using mitral clips in the national clinical guidelines
14. Reimbursement analysis in Switzerland
14.1. Overview of the reimbursement system
14.2. Reimbursement for transcatheter mitral valve leaflet repair using mitral clips
14.2.1. Procedure coding
14.2.2. Diagnosis coding
14.2.3. Payment mechanism and reimbursement tariffs
14.2.4. Policy considerations
14.2.4.1. Restrictions for percutaneous interventional treatment of severe mitral valve insufficiency in the Health Benefit List
14.2.4.2. The Swiss Mitraclip Registry
15. Disclaimer
11
Sep 2019
In August 2019, the mini-HTA for Tendyne transcatheter mitral valve implantation system was initiated by Oslo University Hospital. The finalized mini-method assessment will be published in the National Database for Mini-HTA.
Read more11
Jun 2018
On 11th May, the Italian Ministry of Health announced from its website that five new Med Tech-related HTA documents are available for public consultation. See the details in the MTRC post.
Read more20
Nov 2017
Annual report from the Italian Society of Interventional Cardiology (GISE) shows increasing trends in procedural volume of percutaneous coronary interventions (PCI), transcatheter aortic valve implantations (TAVI), mitral clip implantations, closure of left atrial appendage (LAA) and patent foramen ovale (PFO).
Read more04
May 2017
Check out reimbursement summary for the most established transcatheter mitral valve repair procedure in England, France and Germany. Reimbursement is established in Germany and France (for one indication). It is in process to be established in England and in France (for other indications).
Read more25
Apr 2017
The procedure can be coded in Austria, Denmark, England, Germany, Italy, Netherlands, Norway, Sweden and Switzerland, so payment mechanism is in place, even with an inadequate tariff in some countries. In countries where the procedure is not coded, it cannot be reimbursed. Despite available reimbursement mechanism, funding has not been established yet in majority of geographies.
Read more10
Apr 2017
Reports presents summary of the reimbursement situation in Europe for all developed or currently under development minimally invasive (transapical approach via mini-thoracotomy) and transcatheter mitral valve repair and replacement procedures for mitral regurgitation.
Read more15
Mar 2017
MTRC is working on release of 9 reimbursement reports for medical technologies during March 2017, including report for transcatheter aortic valve replacement and eight minimally invasive mitral valve repair and replacement procedures.
Read more